News & Media

Kaneka Corporation (Osaka, Japan; President: Mamoru Kadokura, herein after referred to as Kaneka) has decided to drastically increase its biopharmaceutical^*1 production capacity in Kaneka Eurogentec S.A. (Seraing, Liege, Belgium; President: Masanobu Sugawara), a wholly owned group company ...

As from October 1, 2015, Kaneka Corporation (further: Kaneka), headquartered in Osaka and Tokyo, establishes a European holding company in Brussels, Belgium, aiming to accelerate its business development in Europe, the Middle East and Africa (further : EMEA). Along with this, Kaneka Belgium, ...

Berlin, 22 June 2017 – European Bioplastics (EUBP), the association representing the interests of the bioplastics industry in Europe, has elected a new Board on 21 June 2017 to serve a two-year term. In a clear vote of confidence, the General Assembly of EUBP affirmed the strategic direction ...

On December 4th, 2013, Kaneka Belgium NV and BASF SE signed a contract for the transfer of BASF’s Impact Modifier and Processing Aid Business, a product line to improve the impact strength and processing of PVC and engineering plastics. The agreement was ...

Kaneka Belgium N.V. (Westerlo, Belgium; President: Masaaki Kimura; hereinafter “Kaneka Belgium”), a subsidiary of Kaneka Corporation (Osaka, Japan; President: Kimikazu Sugawara) has reached an agreement on acquiring the acrylic-based modifier* business of BASF SE ...